Clinical Trial Update: Atomoxetine for Children With Acquired Attentional Disorders Following Completion of Chemotherapy for ALL [Phase 4]

View source ↗

Summary

A Phase 4 trial of atomoxetine in children with acquired attentional disorders after ALL chemotherapy has been terminated; the study status has been updated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Atomoxetine (Atomoxetine)

Snippet

Sponsor: Monarch Medical Research | Conditions: Attention Deficit Hyperactivity Disorder | Phase 4 | Status: TERMINATED